Q3 2026

Quarterly Watchlist

Structural pressure points in the isotope economy this quarter. Not news. Not prices. Why these items are worth watching now.

Q3 2026 watchlist. Next scheduled review: Q4 2026.

Active items

Diagnostic supply remains concentrated in a small production network. Outage risk is still a system-level issue, not a resolved background detail.

Therapeutic demand continues to outpace easy capacity expansion. Processing and reactor access remain the binding constraints.

Clinical interest is rising faster than proven, scalable production routes. Availability is still the gating item.

Quantum hardware demand is pushing high-purity Si-28 from research specialty toward materials-input status.

Advanced reactor timelines still depend on enrichment capacity that is being rebuilt, not already abundant.

Limited production pathways and competing strategic uses leave little spare capacity in the system.

The rest of the hub is the permanent map. This page is the quarterly pressure layer on top of it.

Items appear here only when there is active structural tension: tight supply, rising demand, constrained routes, or unfinished capacity rebuilds.

Directory entries explain what something is. This list only answers why it is under pressure now.